Viral Hepatitis
Copyright ©2005 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jan 28, 2005; 11(4): 476-481
Published online Jan 28, 2005. doi: 10.3748/wjg.v11.i4.476
Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease
Yukiko Saitou, Katsuya Shiraki, Yutaka Yamanaka, Yumi Yamaguchi, Tomoyuki Kawakita, Norihiko Yamamoto, Kazushi Sugimoto, Kazumoto Murata, Takeshi Nakano
Yukiko Saitou, Katsuya Shiraki, Yutaka Yamanaka, Yumi Yamaguchi, Tomoyuki Kawakita, Norihiko Yamamoto, Kazushi Sugimoto, Kazumoto Murata, Takeshi Nakano, First Department of Internal Medicine, Mie University School of Medicine, Tsu, Mie 514-8507, Japan
Author contributions: All authors contributed equally to the work.
Correspondence to: Katsuya Shiraki, M.D., Ph.D. Assistant Professor, First Department of Internal Medicine, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan. katsuyas@clin.medic.mie-u.ac.jp
Telephone: +81-59-231-5015 Fax: +81-59-231-5201
Received: March 5, 2004
Revised: March 10, 2004
Accepted: May 29, 2004
Published online: January 28, 2005
Core Tip